miLab showed almost equivalent to WHO-certified first-degree microscopy experts: Sensitivity of 94.4%, Specificity of 98.1%African authority on malaria diagnosis said...
PALO ALTO, Calif., April 25, 2024 /PRNewswire/ -- Orchid, a reproductive technology company offering the world's only commercially available whole...
SAN DIEGO and CALGARY, AB, April 25, 2024 /PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company...
Neha Krishnamohan brings extensive experience across strategic growth, business development, M&A and financing Jennifer Bush, Esq., who brings 14 years...
NEW YORK--(BUSINESS WIRE)--#biotech--Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced today the enrollment of the first patient in...
Ad hoc announcement pursuant to Art. 53 LR Giovanni Di Napoli appointed as new CEO effective from 24 May 2024....
TAMPA, Fla., April 24, 2024 /PRNewswire/ -- St. Joseph's Hospital today announced that it becomes the first health care facility...
LEESBURG, VA / ACCESSWIRE / April 24, 2024 / A partnership with HealthWorks for Northern Virginia brings Rezolut, the parent...
Expedited checkout requires limited staff overnight, enabling nearly 24/7 accessSCOTTSDALE, Ariz.--(BUSINESS WIRE)--Quickcharge, a dining and retail technology platform for Healthcare,...
Additional ASCO 2024 poster presentation will include new findings from the Phase 2 study of tulmimetostatPLANEGG and MUNICH, GERMANY /...
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness,...
Organizational redesign and rightsizing initiated across company to streamline structures, increase efficiency and reduce operating costsTogether with GSK, ended Pandemic...
Mr. Ramanayake brings more than fifteen years of experience in biopharma company development and deal-makingStrong track record of successful clinical...
Phase 1 part of combined Phase 1/2 study initiated as part of pandemic preparedness against highly pathogenic avian influenza (H5N1)...
TORONTO, ON / ACCESSWIRE / April 24, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF)(FRA:TTX), a clinical stage...
LUND, SWEDEN / ACCESSWIRE / April 24, 2024 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) Spago Nanomedical AB (publ) announced today data from...
ANGLE signs agreement to tailor existing Parsortix-based DNA damage response assay for use in pharmaceutical R&D GUILDFORD, SURREY / ACCESSWIRE...
An automated outbreak detection tool reduced the size of outbreaks by 64% in the trial period preceding the COVID-19 pandemic...
Relatient’s centralized scheduling platform and patient self-scheduling tools will enhance patient access while streamlining staff workflowsATLANTA--(BUSINESS WIRE)--#DashEngage--Anne Arundel Dermatology (AADerm),...
Presentation on Monday, April 29th at 4:15 PM (GMT+1)HOUSTON, TX / ACCESSWIRE / April 23, 2024 / CNS Pharmaceuticals, Inc....